Dierk Scheinert, MD
Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Tuesday, November 14, 2017 |
Session Moderator
|
Wednesday, November 15, 2017 |
Presenter
2-Year Value Of The Lutonix DCB (Bard) For the Treatment Of Fem-Pop Occlusive Lesions In A RCT vs. POBA: Do The Benefits Persist And What Are They In Long Complex Lesions
11:08 AM - 11:13 AM
|
Presenter
1-Year Results With The Ranger DCB (Boston Scientific) For The Treatment Of Fem-Pop Lesions: Equivalent Benefits In Diabetic Patients And 12-Month All Comer Registry Data
11:20 AM - 11:25 AM
|
Presenter
DCBs And DESs Produce Equivalent Results At 2-3 Years With Short SFA Lesions But DESs Are Better For Long Lesions: From The REAL-PTX RCT
11:50 AM - 11:55 AM
|
previous | next |